FILING ANALYSIS · MONDAY, NOVEMBER 2
CorMedix Inc. CRMD — 8-K: Results of Operations and Financial Condition
neutral
CorMedix Inc. reports a cash position of $355 million as of September 30, 2026, and reaffirms its total revenue guidance for 2026, but this news is likely already priced in, and there are no quantified surprises that would significantly impact the stock price
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →